Liminatus Pharma Inc. Class A-28LIMNWPreferred / convertible
13F holders, Q3 2025 (September 30)26holders +1
2new positions
1sold out
1famous investor
$0.15avg. 13F price*
At the end of Q3 2025, 26 institutions reported holding Liminatus Pharma Inc. Class A-28 (LIMNW) in their 13F filings, up 1 from Q2 2025. 2 opened new positions and 1 sold out. The largest holders were Clear Street Group Inc. ($119K), Aristeia Capital, L.L.C. ($47K) and Linden Advisors LP ($40K). One famous investor held it David E. Shaw ( of D. E. Shaw & Co.'s portfolio).
- Company
- Liminatus Pharma Inc. Class A-28
- CUSIP
- 53271X116
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $16K |
| Exits | 1 | $210K |
All 13F filers, Q2 2025 → Q3 2025: 133,597 shares bought and 922,887 shares sold, net −789,290 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 26 holders
| Clear Street Group Inc. | — | — | 805,377 | $119K |
| Aristeia Capital, L.L.C. | — | Add +2.0% | 319,510 | $47K |
| Linden Advisors LP | — | No change | 268,199 | $40K |
| Saba Capital Management, L.P. | — | No change | 233,761 | $35K |
| Moore Capital Management, LP | — | No change | 125,000 | $18K |
| Polar Asset Management Partners Inc. | — | No change | 122,688 | $18K |
| MMCAP International Inc. SPC | — | No change | 111,745 | $17K |
| Nomura Holdings Inc. | — | New | 97,325 | $12K |
| Alpha Wave Global, LP | — | No change | 89,098 | $11K |
| D. E. Shaw & Co. | — | No change | 83,353 | $10K |
| Wolverine Asset Management LLC | — | Reduce -39.0% | 62,863 | $9K |
| Blue Owl Capital Holdings LP | — | No change | 50,000 | $7K |
| Periscope Capital Inc. | — | Reduce -5.0% | 47,500 | $7K |
| Toronto Dominion Bank | — | Reduce -0.3% | 35,100 | $5K |
| GTS Securities LLC | — | New | 30,000 | $4K |
| LMR Partners LLP | — | No change | 29,961 | $4K |
| Arena Capital Advisors, LLC- CA | — | No change | 29,166 | $4K |
| Jane Street Group, LLC | — | Reduce -9.3% | 24,427 | $4K |
| Limestone Investment Advisors LP | — | No change | 22,562 | $3K |
| Cubist Systematic Strategies, LLC | — | No change | 15,778 | $2K |
| Meteora Capital, LLC | — | No change | 15,000 | $2K |
| Flow Traders U.S. LLC | — | No change | 13,110 | $2K |
| Dupont Capital Management Corp. | — | No change | 6,250 | $925 |
| HGC Investment Management Inc. | — | No change | 1,250 | $185 |
| UBS Group AG | — | Reduce -85.6% | 290 | $43 |
| Bank of America Corp. | — | Reduce -33.3% | 200 | $29 |
"% of holder's portfolio" is LIMNW's weight in each manager's 13F, not the share of Liminatus Pharma Inc. Class A-28 the manager owns.